NCCN-protocol care · 96.9% 1-yr breast cancer survival · ArogyaSri, CGHS & cashless insurance accepted · Free second opinion
1800 202 8726
Myths & Misinformation

Myth: Immunotherapy Cures All Cancers

No — immunotherapy does not cure all cancers, and no oncologist can promise a cure to any individual patient. In a proportion of patients with certain cancers, checkpoint inhibitors produce long, sometimes years-long remission, but response depends heavily on cancer type, biomarkers, and stage, and many patients see limited or no benefit at all.

Medically reviewed by Dr. Bharati Devi Gorantla, Medical Oncologist · MBBS · MD · DM (Adyar, Chennai) · ECMO · MRCP SCE (UK) · Last reviewed August 2026

  • Not a universal cure — immunotherapy works well for some cancers and barely at all for others; there's no single answer for everyone
  • Response isn't guaranteed — biomarker tests like PD-L1 and MSI help predict who's more likely to benefit, but can't promise an outcome
  • Long remission isn't the same as cure — some patients stay cancer-free for years, which doctors describe as a durable response, not a cure
  • Honest expectations, set upfront — our tumour board discusses your realistic chances before treatment starts, with no inflated promises
4.8 · 800+ Google reviews · 15,000+ patients treated
Limited Slots Today

Get an Honest Immunotherapy Assessment

₹950   Today: FREE  ·  Including free written second opinion

Doctor-led 45-min consultation
Tumour board for every patient
Confidential. No commitment to start treatment.
or
Call 1800 202 8726
17+
Cancer Specialists
on Panel
96.9%
Breast Cancer
Survival Rate*
15,000+
Patients
Treated
4.8★
Google Rating
(800+ reviews)
Start Here

Can immunotherapy cure cancer?

No treatment, including immunotherapy, can promise a cure for cancer, and immunotherapy is no exception. What it can do, in a proportion of patients with specific cancers and biomarkers, is trigger the immune system to control or shrink tumours for an extended period — sometimes for years. Oncologists call this a durable response, and it is deliberately not the same word as cure.

Headlines describing immunotherapy as a "breakthrough" or a "miracle" summarise the most striking clinical trial results, not the typical patient's outcome. Those stories are real, but they are the exception being reported precisely because they are exceptional — most coverage doesn't have room to explain the full range of outcomes, including patients for whom the same drug did very little.

Part of the confusion is the name itself: "immunotherapy" sounds like it simply boosts your immunity, the way a supplement or diet change might. In reality, it's a precise, prescription-only drug treatment that blocks specific signals cancer cells use to hide from the immune system — a targeted mechanism, not a general immunity boost.

Did you know?

In advanced melanoma and certain lung cancers, some patients treated with checkpoint inhibitors have maintained a durable response for five years or more in published clinical trials. This outcome is genuinely encouraging, but it does not occur for most patients or most cancer types. (Source: NCCN and ASCO immunotherapy guidance, 2024.)

Realistic Expectations

What proportion of patients respond to immunotherapy?

Response depends enormously on the specific cancer type and its biomarkers — there is no single number that applies to everyone. This table shows the pattern, not a prediction for any one patient.

Cancer type Typical role of immunotherapy What most patients can realistically expect
Advanced melanoma Often used first, alone or in combination A meaningful share of patients get a durable response; long-term remission is realistic but not universal
Non-small cell lung cancer Frequently combined with chemotherapy Response depends heavily on PD-L1 expression; not every patient qualifies or responds
Kidney cancer (renal cell) A standard option in advanced disease Combination regimens improve the odds compared with either treatment alone
Bladder & urothelial cancer Used after, or sometimes instead of, chemotherapy Response varies considerably; a meaningful proportion see limited benefit
Many other solid tumours Still being studied, or used selectively Response rates are generally lower, and immunotherapy may not be recommended at all

Patterns follow NCCN and ASCO treatment guidance. Only a review of your own reports and biomarkers can tell you what to realistically expect — use this table to understand the picture, not to predict your own outcome.

Wondering if immunotherapy could help you?

Get a free, realistic assessment of whether checkpoint inhibitor immunotherapy fits your specific cancer and stage.

or
Call 1800 202 8726
12+ Centres in Hyderabad · Pick yours

CION cancer care is closer than you think.

We're never more than 30 minutes away. Same panel of specialists at every centre. Same tumour board reviews. Same NCCN protocols. Pick the closest one and call directly — or let us pick for you.

Not sure which centre fits best? Tell us where you are — we'll suggest the closest one with the right specialists.

Help me pick the right centre
Meet the Specialists

17+ senior cancer specialists. One panel for your case.

Trained at AIIMS, Tata Memorial, and leading international centres. Combined 150+ years of experience. Every complex case is reviewed by 3+ of them — together.

Dr. Naresh Gundu
Medical Oncologist

Dr. Naresh Gundu

MBBS, DNB (Internal Medicine), DM (Medical Oncology)

View Profile
Dr. C. Raghavendra Reddy
Medical Oncologist

Dr. C. Raghavendra Reddy

MBBS(Gold Medal), DNB(General Medicine), DM(Medical Oncology)(Gold Medal)

View Profile
Dr. Bharati Devi Gorantla
Medical Oncologist

Dr. Bharati Devi Gorantla

MBBS, MD(General Medicine), DM(Medical Oncology)(Adyar,Chennai), ECMO, MRCP SCE(UK)

View Profile
Dr. Owais Mohammed
Medical Oncologist

Dr. Owais Mohammed

MBBS, MD (General Medicine), DrNB (Medical Oncology), ECMO, MRCP SCE (Medical Oncology) (UK)

View Profile
Dr. T. Raghavender Reddy
Medical Oncologist

Dr. T. Raghavender Reddy

MBBS, DM (Medical Oncology), MD (Radiation Oncology)

View Profile
Dr. N. Kiranmayee
Medical Oncologist

Dr. N. Kiranmayee

MBBS, DM (Medical Oncology), MD (Internal Medicine)

View Profile
Dr. Muralidhar Muddusetty
Surgical Oncologist

Dr. Muralidhar Muddusetty

MBBS (AIIMS), MS (Surgery) (AIIMS), DNB (Surgical Oncology), MRCS (Edinburgh)

View Profile
Dr. Raghavendra Naik
Surgical Oncologist

Dr. Raghavendra Naik

MBBS, MS (General Surgery), M.Ch (Surgical Oncology)

View Profile
Dr. Mohammed  Imaduddin
Surgical Oncologist

Dr. Mohammed Imaduddin

M.B.B.S, MS (General Surgery), M.Ch (Surgical Oncology)

View Profile
Dr. Vinay Mamidala
Surgical Oncologist

Dr. Vinay Mamidala

MBBS, MS(General Surgery), M.Ch(Surgical Oncology), FMAS, FARIS(Ongoing)

View Profile
Dr. Paila Gowri Naidu
Surgical Oncologist

Dr. Paila Gowri Naidu

MBBS, MS (General Surgery), M.Ch (Surgical Oncology), FMAS

View Profile
Dr. Venkata Sushma P
Radiation Oncologist

Dr. Venkata Sushma P

MBBS, MD (Radiation Oncology)

View Profile
Dr. Kirti Ranjan Mohanty
Radiation Oncologist

Dr. Kirti Ranjan Mohanty

MBBS, MD (Radiation Oncology)

View Profile
Dr. Gangadhar Vajrala
Radiation Oncologist

Dr. Gangadhar Vajrala

MBBS, MD (Radiation Oncology), MPH

View Profile
Dr. Basudev Pokhrel
Hematologist

Dr. Basudev Pokhrel

MBBS, M.D (Immunohematology & Blood Transfusion)

View Profile
Dr. Mohammed Imran
Interventional Radiologist

Dr. Mohammed Imran

View Profile
Dr. Vajja Sandeep Kumar
Surgical Oncologist

Dr. Vajja Sandeep Kumar

MBBS, MS (General Surgery), DrNB (Surgical Oncology), FALS Oncology

View Profile
Dr. Sridhar Kamani
Surgical Oncologist

Dr. Sridhar Kamani

MBBS, MS (General Surgery), DrNB (Surgical Oncology)

View Profile

Want a specific doctor for your case? Mention them when booking.

Book Free Consultation

Get facts, not false hope

Speak to a CION oncology team member for an honest, personalised view of what immunotherapy can — and can't — do for you.

Book Free Consultation Call 1800 202 8726
Where It Comes From

Where does the "immunotherapy cures all cancers" myth come from?

Media coverage has created expectations no single treatment can meet. None of these sources are dishonest on their own — the problem is what gets left out.

Media coverage

Breakthrough headlines

News stories about a single patient's remarkable recovery are newsworthy precisely because they are unusual, not because they are typical.

Confusing terms

"Immune" sounds familiar

The word immunotherapy sounds like it simply boosts the immune system the way a supplement might. The reality is a precise, drug-based treatment that unblocks specific immune signalling.

Survivor stories

Social media testimonials

Individual success stories shared online are real but selective — they rarely mention the patients for whom the same treatment didn't work as well.

Hope under pressure

A word families want to be true

For a family facing a cancer diagnosis, "cure" is the word everyone hopes to hear, which makes hopeful headlines especially easy to believe.

A Clearer Vocabulary

What does "response" mean, if not cure?

Oncologists use specific terms that describe outcomes more precisely than "cure" — each one means something different for what happens next.

  • Complete response — no detectable cancer on scans, though monitoring continues, since microscopic disease can remain undetected.
  • Partial response — the tumour has shrunk significantly but hasn't disappeared.
  • Stable disease — the cancer has stopped growing, without shrinking further.
  • Durable response — a response, complete or partial, that lasts for an extended period, sometimes years.
  • Progression — the cancer continues to grow despite treatment, which happens in a meaningful proportion of patients.

Which of these applies to you depends on your specific cancer type, its biomarkers, and how it responds — something only testing and a tumour board review can tell you. For some patients, after weighing side effects against expected benefit, the right decision is not to pursue immunotherapy at all. That is a legitimate option your oncologist should discuss with you, not a failure.

Already started immunotherapy and unsure what to expect?

Share your reports or scan results for a free, doctor-led review of your specific response.

or
Call 1800 202 8726
Related Reading

Correcting the wider "immunity" confusion

This page is for general information and does not replace a consultation. If you're weighing whether immunotherapy is right for your specific diagnosis, discuss it directly with your oncology team.

You're not alone

Thousands of families have asked us this same question

Understanding what immunotherapy can realistically offer is the first step to making a confident treatment decision.

Book Free Consultation Call 1800 202 8726
Real Stories. Real Voices.

15,000+ patients chose CION. Hear from them directly.

These aren't paid endorsements or written reviews. These are video testimonials from real patients and families — recorded on their own phones, in their own words. Pick any one. Watch it. Then decide.

4.8★800+ Google reviews
50+video testimonials
15,000+patients treated

Successful Chemotherapy Done by Dr. C Raghavendra Reddy

Watch video →

Surgery, Chemo & Radiation Done by Dr. Imaduddin, Dr. Vinay, Dr. Owais, Dr. Kirti

Watch video →

Successful Radical Thymectomy Done by Dr. Mohammed Imaduddin & Dr. Vinay Mamidala

Watch video →

Successful Surgery Done by Dr. Rajender Byshetty

Watch video →

Successful Chemo & Surgery Done by Dr. Imad, Dr. Vinay, Dr. Owais & Dr. Raghavendra

Watch video →

Successful Chemo & Surgery Done by Dr. Imad, Dr. Vinay, Dr. Owais & Dr. Raghavendra

Watch video →

Successful Chemo & Radiation Done by Dr. Owais Mohammed & Dr. Kirti Ranjan Mohanty

Watch video →

Successful Breast Cancer Surgery Done by Dr. Imaduddin Mohammed & Dr. Vinay Mamidala

Watch video →

Successful Chemotherapy Done by Dr. Bharati Devi Gorantla

Watch video →

Successful Chemo & Surgery Done by Dr. Owais Mohammed & Dr. Imaduddin Mohammed

Watch video →

Successful Chemotherapy Done by Dr. Gundu Naresh

Watch video →

Successful Bone Marrow Transplantation - Neuroblastoma

Watch video →

Successful Surgery & Chemo - Carcinoma of Caecum

Watch video →

Successful Oral chemotherapy & mastectomy surgery

Watch video →

Successful Oral chemotherapy & mastectomy surgery

Watch video →

Successful Chemotherapy

Watch video →

Successful Surgery by Dr. Mohammed Imaduddin

Watch video →

Successful Bone Marrow Transplantation

Watch video →

Successful Oral chemotherapy & mastectomy surgery

Watch video →

Successful Oral chemotherapy & mastectomy surgery

Watch video →

Successful Chemotherapy

Watch video →

Successful Buccal Mucosa Surgery

Watch video →

Successful Complex Surgery Mandibulectomy Reconstruction

Watch video →
Common questions

Immunotherapy and the cure myth: your questions answered

Does immunotherapy cure cancer?
No single treatment, including immunotherapy, offers a guaranteed cure for cancer. In a proportion of patients with certain cancers such as advanced melanoma or lung cancer, checkpoint inhibitors can produce a durable response — meaning the disease is controlled or significantly reduced, sometimes for years. This is different from a cure, since it doesn't mean every trace of cancer is permanently gone, and doctors continue monitoring for recurrence. Whether immunotherapy is suitable for you, and what outcome to realistically expect, depends on your specific cancer type, stage, and biomarker results, which your oncology team reviews before recommending it.
Why do so many people believe immunotherapy cures all cancers?
The belief usually comes from three sources: media coverage that highlights the most dramatic recovery stories rather than typical outcomes, the word immunotherapy itself sounding like a general immunity boost rather than a precise drug treatment, and social media posts from individual survivors that don't mention the many patients for whom the same treatment didn't work as well. None of these sources are dishonest, but together they create expectations that don't match the full clinical picture, which is why an honest conversation with your oncologist matters more than headlines.
Which cancers respond best to immunotherapy?
Checkpoint inhibitor immunotherapy has the strongest and most established role in cancers such as advanced melanoma, non-small cell lung cancer, kidney cancer, and certain bladder and head and neck cancers, according to NCCN and ASCO treatment guidelines. Even within these cancers, response depends on individual factors like PD-L1 expression, tumour mutation burden, and overall health. For many other cancer types, immunotherapy plays a smaller role or isn't yet a standard option. Your oncologist can tell you where your specific diagnosis fits based on your pathology and biomarker reports.
What does it mean if my scans show a response but not a cure?
It means the treatment is working in a meaningful way — the tumour may have shrunk (a partial response) or become undetectable on imaging (a complete response) — but your medical team isn't calling it a cure because microscopic cancer cells can sometimes remain undetected, and there is still a chance of recurrence. Many patients with a durable response continue routine monitoring for years. This is genuinely good news; it's just described precisely rather than with a word that promises more than medicine can guarantee.
What happens if immunotherapy doesn't work for me?
If scans or blood tests show the cancer isn't responding, your oncology team reassesses and discusses other options, which may include a different immunotherapy combination, chemotherapy, targeted therapy, radiation, clinical trials, or in some cases best supportive care, depending on your situation. Immunotherapy not working for one person says nothing about whether other treatments will help, and it's not a reflection of anything the patient did. A tumour board review at this stage helps make sure every reasonable option has genuinely been considered before moving forward.
Is immunotherapy the same as boosting my immunity naturally?
No. Immunotherapy is a specific, prescription-only drug treatment that blocks particular signals cancer cells use to hide from the immune system, given under close medical supervision with regular monitoring for side effects. It is not the same as vitamins, immunity drinks, or general wellness practices that claim to boost immunity, even though the names sound similar. If you're considering a traditional or complementary practice alongside immunotherapy, tell your oncology team first, since some can interact with treatment or its side-effect management.
Call now Book free consultation